Does President Trump Have an Interest in the Company That Makes Hydroxychloroquine?
The New York Times reported Monday that President Trump has “a small personal financial interest in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine,” a drug that the president has been advocating the use of to combat coronavirus. To be exact, according to Trump’s financial disclosure for 2018 “his three family trusts each had investments in a Dodge & Cox mutual fund, whose largest holding was in Sanofi.”
Confusion over how best to interpret the numbers quickly flooded Twitter, with some overplaying the significance of Trump’s investments:
Start a Free Trial
Get every newsletter and all of The Dispatch. Support quality, fact-based journalism.
Get Started
ALREADY HAVE AN ACCOUNT?
SIGN IN
About Alec Dent
Alec Dent is the culture editor and a staff writer for The Dispatch. He is a graduate of the Hussman School of Journalism and Media at UNC Chapel Hill, and previously oversaw The Dispatch's fact checking team.